NCT05713799

Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2026-06-14Est. Completion: 2030-03-01

Enrollment target: 60 participants

Locations

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Contact

Ashley M Schmitz, C.R.N.P.ashley.schmitz@nih.gov (920) 948-1186

Aaron M Cypess, M.D.aaron.cypess@nih.gov (301) 435-9267

Other microbiome trials you might be interested in

The Effect of a Structured Strength and Endurance Training Program on Quality of Life, Fitness, Blood Parameters and Survival in Prostate Cancer PatientsRecruiting

Prostate CancerMetastatic Prostate CancerProstate Cancer (Post Prostatectomy)Prostate Cancer Patients Treated by RadiotherapyProstate Cancer Non-Metastatic

Prostate cancer is the second most common cancer among men. Many patients experience a significantly reduced quality of …

Munich, GermanyEst. completion Jul 31, 2026

View Trial →

Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical TrialRecruiting

Healthy Volunteer

Background: As people age, the cells in the pancreas that produce insulin begin to release less of this hormone, and le…

Baltimore, United StatesEst. completion Mar 31, 2027

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.